Market Cap | 268.82K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
Income | -3.54M | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -6.00% |
Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -50.00% |
Recommedations | - | Quick Ratio | 0.01 | Shares Outstanding | 2.69B | 52W Low Chg | - |
Insider Own | - | ROA | -321.39% | Shares Float | - | Beta | 25.94 |
Inst Own | 0.00% | ROE | - | Shares Shorted/Prior | -/- | Price | 0.00010 |
Gross Margin | - | Profit Margin | - | Avg. Volume | 310,166 | Target Price | - |
Oper. Margin | - | Earnings Date | - | Volume | 805,001 | Change | 0.00% |
Pazoo, Inc. operates as a health and wellness company. It offers laboratory testing services for marijuana. Pazoo, Inc.was formerly known as IUCSS, Inc. and changed its name to Pazoo, Inc. in May 2011. The company was founded in 2010 and is headquartered in East Hanover, New Jersey.